Explore 3 Stock Ideas & Industry Insights Download Free Report
Hikma is the surprise FTSE 250 name in this trio. The Jordanian-founded, London-listed drugmaker spent years as a FTSE 100 constituent, but was relegated to the mid-cap index with effect from 23 March 2026 after its share price weakened following a guidance reset. That …
According to market-data compilations, ProBiotix featured among the day's larger fallers on the London market, with the quoted decline in the region of 10%. For a company of ProBiotix's size, a percentage move of this scale can be triggered by only a handful of …
Thalia Therapeutics plc LSE:THAT has attracted renewed investor attention after rising14.36% on 15 September 2026.
4basebio LSE:4BB is attracting attention because the company sits at the intersection of several rapidly developing healthcare themes, includingsynthetic DNA, personalised medicine, mRNA therapeutics, gene therapy, cell therapy and gene editing.
Proteome Sciences plc LSE:PRM has emerged as another notable UK healthcare mover on15 September 2026, with its shares gaining14.29%.
AstraZeneca PLC — LSE:AZN fell 0.31% on15 September 2026, with the shares closing at 12,115.00p, down 38.00p on the day.
ConvaTec Group PLC — LSE:CTEC fell 0.37% on15 September 2026, with the shares closing at 216.60p, down 0.80p on the day.
GSK PLC — LSE:GSK rose 0.22% on15 September 2026, with the shares closing at 1,858.50p, up 4.00p on the day.
Haleon PLC — LSE:HLN fell 0.76% on15 September 2026, with the shares closing at 339.60p, down 2.60p on the day.
Smith & Nephew PLC — LSE:SN. fell 0.29% on15 September 2026, with the shares closing at 1,045.50p, down 3.00p on the day.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…